DoJ Investigating Lilly's AMP Reporting, Despite Lack Of Final Rule
This article was originally published in The Pink Sheet Daily
Lilly revealed that the US Department of Justice is investigating how it treats distribution service agreements with wholesalers when reporting average manufacturer price to CMS – one of the topics that is supposed to be addressed in the yet-unpublished final AMP rule. The government is also looking into contracting and pricing of Merck's Dulera.
Register for our free email digests: